截至2025年9月12日收盘，国瓷材料(300285)报收于23.62元，下跌3.63%，换手率3.23%，成交量27.2万 手，成交额6.45亿元。 当日关注点 交易信息汇总资金流向 来自交易信息汇总：9月12日主力资金净流出3822.65万元，散户资金净流入4402.62万元。 来自违规处罚提醒：副总经理许少梅因未依法履行其他职责被山东证监局责令改正。 9月12日主力资金净流出3822.65万元；游资资金净流出579.98万元；散户资金净流入4402.62万元。 违规处罚提醒监管公告 9月11日国瓷材料公开信息显示，山东国瓷功能材料股份有限公司副总经理许少梅因未依法履行其他职 责被中国证券监督管理委员会山东监管局责令改正。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

Investment Rating - The report maintains a "Recommended" rating for the chemical industry [1] Core Insights - The chemical industry in China is expected to undergo a revaluation due to anti-involution measures, which may lead to a significant slowdown in global chemical capacity expansion. This shift could enhance the cash flow and dividend yield of Chinese chemical companies, transforming them from cash-consuming entities to profit-generating ones [6][29] - The demand for chromium salts is anticipated to rise significantly due to increased orders for gas turbines and commercial aircraft engines in Europe and the US, leading to a projected shortfall of 250,000 tons by 2028, which is about 23% of the total annual production [6] - The report highlights four key investment opportunities: low-cost expansion, improving industry conditions, new materials, and high dividend yields from state-owned enterprises [7][8] Summary by Sections Recent Performance - The basic chemical sector has shown a performance increase of 51.0% over the past 12 months, compared to 42.5% for the CSI 300 index [4] Investment Recommendations - The report emphasizes the potential for low-cost expansion in major companies such as Wanhua Chemical, Hualu Hengsheng, and others, alongside sectors like tires and fertilizers [7] - It also points out the improving conditions in various segments, including chromium salts, phosphate rock, and agricultural chemicals [8] Key Products Analysis - Recent price increases were noted for acrylic acid and esters, with butyl acrylate priced at 7,600 RMB/ton, reflecting a 3.40% increase [10] - The report also mentions the price of polymer MDI in East China at 15,550 RMB/ton, up by 1.97% [10] Company Tracking and Earnings Forecast - The report provides a detailed earnings forecast for key companies, indicating a positive outlook for many, with several companies rated as "Buy" [30]

Investment Rating - The report maintains a "Positive" rating for the chemical industry [6][12]. Core Insights - The macroeconomic judgment indicates that non-OPEC countries are expected to lead an increase in oil production, with a significant overall supply growth anticipated. Global GDP growth is projected to remain at 2.8%, with stable oil demand, although the growth rate may slow due to tariff policies [6][7]. - The expectation of a Federal Reserve interest rate cut is likely to boost demand during the peak season of September and October. Additionally, the leakage incident of GFL R32 in India may enhance China's export opportunities [6][12]. - The report highlights the ongoing investigation into anti-dumping practices against imported semiconductor chips from the U.S., which may benefit domestic semiconductor materials [6][12]. Summary by Sections Macroeconomic Analysis - Oil supply is expected to increase significantly, driven by non-OPEC production, while demand remains stable despite potential slowdowns due to tariffs. Geopolitical factors, including U.S.-China tariff relief and the Russia-Ukraine situation, are influencing oil prices [6][7]. - Coal prices are anticipated to stabilize at a low level, and natural gas export facilities in the U.S. may accelerate, leading to lower import costs [6][7]. Chemical Sector Configuration - The report suggests a strategic focus on four areas: textile and apparel chain, agricultural chemicals, export chain, and sectors benefiting from "de-involution" policies. Specific companies are recommended for investment based on their market positions and growth potential [6][12]. Key Material Focus - Emphasis is placed on the importance of self-sufficiency in key materials, particularly in semiconductor and panel materials, with specific companies highlighted for their potential in these sectors [6][12]. Price Trends - Recent data indicates fluctuations in various chemical prices, with PTA prices down by 0.3% and MEG down by 2.0%. The report notes that the overall industrial product PPI has shown a year-on-year decline of 2.9% [12][13][16]. Company Valuations - A detailed valuation table is provided, showcasing various companies in the agricultural chemicals and chemical sectors, with ratings ranging from "Buy" to "Increase" based on their market performance and projected earnings [20].

Group 1 - The company announced the establishment of a joint venture focused on the research and industrialization of solid-state electrolyte materials [2] - The joint venture was approved during the company's fifth board meeting held on August 17, 2025 [2] - The joint venture has completed its business registration and obtained a business license from the Dongying Economic and Technological Development Zone Market Supervision Administration [2]

本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 山东国瓷功能材料股份有限公司（以下简称"公司"）于2025年8月17日召 开第五届董事会第二十三次会议，审议通过了《关于对外投资设立合资公司的 议案》，同意公司与王琰先生共同出资设立合资公司，专注于固态电解质材料 的研发与产业化，具体内容详见公司于2025年8月19日在中国证监会指定创业板 信息披露网站上披露的《关于对外投资设立合资公司的公告》（公告编号： 2025-033）。 山东国瓷功能材料股份有限公司 关于合资公司完成工商注册登记的公告 证券代码：300285 证券简称：国瓷材料 公告编号：2025-053 近日，该合资公司完成工商注册登记，并取得东营经济技术开发区市场监 督管理局颁发的《营业执照》，相关登记信息如下： 特此公告！ 山东国瓷功能材料股份有限公司 董事会 2025 年 9 月 12 日 8、经营范围：一般项目：新材料技术研发；电子专用材料研发；电子专用 材料制造；电子专用材料销售；新型陶瓷材料销售；表面功能材料销售；新型 膜材料制造；新型膜材料销售；特种陶瓷制品制造；特种陶瓷制品销售；高性 能 ...

Core Insights - The article discusses the evolution of policies supporting the development of the biomedical materials industry in China, highlighting a shift from basic research support to industrialization, innovation-driven growth, and high-quality development [1][3]. Policy Overview - Since 2015, multiple government departments, including the State Council and the National Health Commission, have issued various policies to support and regulate the biomedical materials industry, focusing on technology development, industry upgrades, quality standards, and centralized procurement [3][4]. - Key policies include the 2024 notification on centralized procurement of high-value medical consumables, aimed at enhancing procurement efficiency and reducing costs [4][5]. - The "14th Five-Year Plan" emphasizes the development of high-end medical devices and key technologies, aiming to improve supply capabilities and address gaps in high-end medical equipment [9][10]. Development Goals - The focus is on technological innovation in high-end implantable products, such as biodegradable vascular stents and artificial joints, as well as new materials like recombinant collagen and biodegradable materials [8][9]. - The government aims to optimize approval processes, promote bulk procurement, and enhance collaboration among academia, industry, and healthcare to boost competitiveness and domestic production levels [8][10]. - By 2025, the goal is to achieve comprehensive coverage of DRG/DIP payment methods in all eligible medical institutions, ensuring a more efficient healthcare financing system [10]. Regional Policies - Various provinces have introduced policies to promote the biomedical materials industry, with a focus on centralized procurement for orthopedic implants and other high-value medical consumables [12][13]. - Cities like Beijing and Shanghai are encouraging the development of new biomedical materials and technologies, including advanced manufacturing techniques and 3D bioprinting [13][14]. - The policies aim to strengthen the local manufacturing capabilities and foster innovation in the biomedical materials sector [14][17].

Core Viewpoint - The governance issues of Guocera Materials have been highlighted due to violations during shareholder meetings, specifically regarding related party transactions and the voting process [2][3][4]. Group 1: Governance Violations - The first violation involves related shareholders not abstaining from voting on related party transactions during shareholder meetings, which undermines the interests of non-related shareholders [4][6]. - The second violation pertains to the counting of votes, where some meetings lacked legal and shareholder representatives, and related shareholders acted as vote counters, violating established rules [4][6]. Group 2: Regulatory Actions - The Shandong Securities Regulatory Bureau and Shenzhen Stock Exchange issued administrative measures against Guocera Materials and its Secretary of the Board, Xu Shaomei, for these governance failures [6][7]. - Xu Shaomei has been held responsible and is required to submit a written rectification report within 30 days, with the violations recorded in the securities market integrity database [6][7]. Group 3: Company Response - Guocera Materials has acknowledged the issues raised and committed to rectifying them, emphasizing that the regulatory measures will not affect its normal business operations [7][8]. - The company has recently held a temporary shareholder meeting to revise governance rules, including the management of related transactions [7].

每经记者｜彭斐 每经编辑｜魏官红 公司股东会审议相关关联交易议案时，关联股东未回避表决，有时还担任计票人⋯⋯国瓷材料的治理问 题被暴露在聚光灯下。 9月11日晚间，国瓷材料（300285.SZ，股价24.51元，市值244.38亿元）公告披露，公司及相关人员近日 收到了中国证券监督管理委员会山东监管局（以下简称"山东证监局"）的行政监管措施决定书和深圳证 券交易所（以下简称"深交所"）出具的监管函。 《每日经济新闻》记者注意到，两份文件直指国瓷材料在过往部分股东大会运作中存在的两大核心程序 漏洞：其一，在部分股东大会审议相关关联交易议案时，关联股东未按规定回避表决；其二，部分股东 大会的计票人、监票人缺少律师和股东代表，个别审议事项由关联股东担任计票人。 山东证监局和深交所的监管文件均明确指出，公司副总经理兼董事会秘书许少梅对上述违规行为负有责 任。 值得注意的是，作为直接责任人，国瓷材料董秘许少梅被采取责令改正的行政监管措施，并被记入证券 期货市场诚信档案数据库。 关联股东"越位"投票，还充当计票人 根据山东证监局出具的决定书内容，国瓷材料此次被查出的问题暴露出公司在公司治理和内部控制方面 存在短板。 第一 ...

证券代码：300285 证券简称：国瓷材料 公告编号：2025-052 山东国瓷功能材料股份有限公司 关于收到中国证券监督管理委员会山东监管局行政监管措 施决定书和深圳证券交易所监管函的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东国瓷功能材料股份有限公司（以下简称"公司"）及相关人员于近日收 到中国证券监督管理委员会山东监管局出具的《关于对山东国瓷功能材料股份有 限公司、许少梅采取责令改正措施的决定》（〔2025〕72 号）（以下简称"《决 定书》"）和深圳证券交易所出具的《关于对山东国瓷功能材料股份有限公司、 许少梅的监管函》（创业板监管函〔2025〕第 116 号）（以下简称"《监管函》"）， 现将相关事项公告如下： 一、《决定书》的主要内容 山东国瓷功能材料股份有限公司、许少梅： 经查，你公司存在以下问题： 一是部分股东大会审议相关关联交易议案时，关联股东未回避表决。二是部 分股东大会的计票人、监票人缺少律师和股东代表，个别审议事项由关联股东担 任计票人。上述行为不符合《上市公司股东大会规则》（证监会公告〔2022〕13 号，下同）第三十一 ...

每经头条（nbdtoutiao）——"史上最丑"与"丑上最薄"：iPhone 17系列背后的新战事 每经AI快讯，2025年9月11日，深交所向山东国瓷功能材料股份有限公司、许少梅发出监管函：根据山 东证监局《关于对山东国瓷功能材料股份有限公司、许少梅采取责令改正措施的决定》，你公司存在以 下违规行为：你公司部分股东大会审议相关关联交易议案时，关联股东未回避表决，不符合《上市公司 股东大会规则》第三十一条第一款的规定。你公司的相关行为违反了本所《创业板股票上市规则》第 1.4条、第5.1.1条和第7.2.10条，以及《创业板股票上市规则》第1.4条、第5.1.1条和第7.2.10条的规定。 你公司副总经理兼董事会秘书许少梅未能勤勉尽责，违反了本所《创业板股票上市规则》第1.4条和第 4.2.2条，以及《创业板股票上市规则》第1.4条和第4.2.2条的规定，对相关行为负有主要责任。请你公 司及相关责任人充分重视相关问题，吸取教训，及时整改，杜绝相关问题的再次发生。 （记者 曾健辉） ...